WITH some fifty other physicians from all over the world I was privileged to see the work on Cortisone at the Mayo Clinic in June 1949, and it so happened that by chance I was called out by Dr. Hench to examine one of the two cases we saw both before and after treatment. There is no doubt in my mind, or I should imagine in the mind of anyone else who was there, of the remarkable changes effected by this drug in rheumatoid arthritis.
As one would expect from such a team as Hench, Kendall, Slocumb and Polley (1949) the work has been most carefully checked and controlled, and the cases which we saw were suffering from severe active rheumatoid arthritis of some standing. We saw two cases before treatment, one with Cortisone and one with A.C.T.H., and the change effected by only two and a half days' treatment was extraordinary. One woman of 55 years had suffered for three years; she could hardly walk and it took her two hours before she could do her hair in the morning. Her sedimentation rate was 67 and she was taking 60 grains aspirin per day. After even such a short period of treatment as two and a half days she was free from pain and we saw her walk normally. She felt a sudden improvement nine hours after the first injection-as she put it "I feel a load taken off"; another remark she made was "I can do anything right away".
The history of the work is a fascinating one, for during the war it was rumoured that the German pilots were being given injections of suprarenal extract to increase their fighting efficiency and so momentum was given to work proceeding on the cortical substances.
For many years Hench (1949) has been studying the reversibility of rheumatoid arthritis and eventually discarded the microbic theory, as he said in his Heberden Oration in this country last year, and turning to the biochemical possibilities he concluded that the "antirheumatic substance X", as he called it, might be an adrenal hormone.
If we are to understand the work done on Cortisone we must study the present-day work on the adrenal steroids.
JAN.-PHYS. MED. 1 All this work is comparatively recent and dates from the 1930's for before that time it was impossible to keep adrenalectomized animals alive long enough to examine the effects of giving cortical substances. So far 28 adrenal steroids have been isolated, but only 6 of them are active as far as is known. These 6 can be divided into three groups. The first contains desoxycorticosterone alone. The second contains corticosterone, dehydrocorticosterone, 17-hydroxy-I 1-dehydrocorticosterone and 17-hydroxycorticosterone. You will see these are all oxygenated at the 11 position and because of this are called 11 oxysteroids. It is this group with which we are principally concerned because it contains Compound E now called Cortisone. This group is also referred to as the glycocorticoids because they are chiefly concerned with carbohydrate metabolism; sometimes they are just called corticoids. The third group is composed of what is left over. There is 17-hydroxy-11-desoxycorticosterone or Compound S which has little effect on carbohydrate metabolism and when the crystalline fractions have been extracted there remains a highly active residue called the amorphous fraction which has been little studied.
Desoxycorticosterone or its acetate D.O.C.A. has been the most studied of these active steroids, as so far it is the only one for which a cheap method of synthetic production has been available and it has been used chiefly for Addison's disease. In 1937 Steiger and Reichstein announced its synthetic preparation from stigmasterol and a little later Reichstein and Van Euw (1938) recovered it from the adrenal cortex. Desoxycorticosterone causes a marked retention of sodium, chloride and water and increases the excretion of potassium and phosphorus; however, it exercises hardly any effect on carbohydrate metabolism. In Addison's disease it will restore the blood electrolyte pattern to normal and elevate the blood-pressure and is life-saving in Addisonian crises. Its continued use can result in cedema and heart failure.
Our group, the 1 I-oxysteroids containing corticosterone, dehydrocorticosterone, 17-hydroxy-1 1-dehydrocorticosterone (Cortisone), 17-hydroxycorticosterone, are concerned chiefly with carbohydrate metabolism.
As early as 1930 Britton enunciated the theory that the "prepotent function" of the adrenal cortex was to regulate carbohydrate metabolism. He observed that the adrenalectomized animals developed acute hypoglycemia and low glycogen levels and that when normal fasted animals were given large doses of cortical extracts there was an increase in blood sugar and in both liver and muscle glycogen. These views were met with misgiving but they now fit into the picture of established fact.
In 1936 Mason, Myers and Kendall, and in 1937 de Fremery and his co-workers isolated corticosterone, now called Compound B, and dehydrocorticosterone, now called Compound A, both extracts of the adrenal cortex, in crystalline form. They found they could maintain adrenalectomized animals in good condition by giving these substances. Kendall (1941) at the Mayo Clinic isolated 17-hydroxy-11-dehydrocorticosterone from the adrenal cortex and called it Compound E; a few weeks later Pfiffner and Kamm (1942) in Switzerland isolated the same compound and called it F. This caused some confusion and the substance is now known as Cortisone. Another compound called S has also been isolated and has the chemical name of 17-hydroxy-1 1-desoxycorticosterone but having no oxygen at C 11 it has no effect on carbohydrate metabolism.
The four compounds, A, B, E and F have a marked effect on carbohydrate metabolism and E, or Cortisone, is by far the most active in this respect. Compound F is so unstable it is difficult to study. Thorn has divided this group into Compounds A and B, the 1 1-oxysteroids, and Compounds E and F, the 1 1-17-oxysteroids, which have an OH group at the 17-position.
They cause an increase in the blood glucose levels and the liver glycogen stores. They cause an increased conversion of protein to carbohydrate and also an increase in tjie renal clearance of uric acid, resulting in the excretion of large quantities of urates both in normal subjects and patients with gout.
Compounds E and F, the 11-17-oxysteroids, have an effect on the lymphoid tissue which is shown by the decrease in the number of circulating eosimophils and also lymphocytes.
The other substance which has been tried is A.C.T.H., the pituitary adrenocorticotrophic hormone. It has recently become available in sufficient quantities to study its effect on the secretion of adrenal steroids in man. It causes a profound fall in circulating eosinophils and a rise in the urinary uric acid excretion. It causes sodium and chloride retention, a rise in blood sugar level, an increase in the excretion of 17-ketosteroids and a rise in the level of circulating 1 1-oxysteroids. In fact in man it ciuses increased secretion of adrenal steroids, giving the effects observed with the crystalline adrenal steroid preparation and of adrenal hormone therapy. In short, t reproduces the effects of Cortisone therapy in rheumatoid arthritis. Now for the clinical effect of Cortisone in more detail. The clinical improvement may start after-only four hours but it is usually felt in the first day or two. The first effect is on the stiffness and the patients say they feel as if something had been unlocked from their limbs. They lose their pain remarkably quickly and joints which were tender on firm pressure become painless. The swelling does not, of course, go so quickly, but I understand that mildly contracted joints have straightened out on Cortisone though I did not see this myself.
These patients get a remarkable euphoria and very often lie awake for the first night or two, free from pain and excitedly planning a future free from arthritis. After this phase they usually fall into a sleep of exhaustion. They acquire a ravenous appetite and eat so much that later they may have to be dieted to avoid obesity. At the International Congress of Rheumatic Diseases in New York last June Dr. Hench showed a film of a patient whom we later met at the Clinic. His joints were tender to firm pressure and he could hardly get up and down steps. After nine days' treatment the film showed he had lost his tenderness and could go up and down the steps quite normally. He offered to run for the film outside the hospital but as there was snow on the ground he was only allowed to do so in the studio.
What about the objective tests? The sedimentation rate comes down to normal but is not so rapid as the remarkable clinical improvement. As Dr. Hench puts it "the B.S.R. and the symptoms are travelling in the same train but not in the same carriage".
The anaemia of rheumatoid arthritis responds to Cortisone alone and no iron or other medication is required. The albumin-globulin ratio reverts to normal.
It was perhaps a stroke of genius which led Hench to try the first case on what might be considered a tremendous dosage for hormone therapy, because if he had not done so he might have missed the bus entirely. Cortisone does not work except in large doses and the cases which we saw which responded so remarkably had 300 mg. the first day and 1QO mg. subsequently. It is given by injection and the drug is so expensive and precious that every precaution is taken to see that none is wasted.
With A.C.T.H. the dosage is smaller but given more frequently and the patient we saw treated had 50 mg. t.d.s. the first day and 25 mg. t.d.s. the second day. I believe the side-effects have been rather over-emphasized but as Hench says: "This stuff is dynamite" and it is extremely important that they should be noted and publicized, because, when this drug becomes available it should not be used except under the most carefully controlled conditions in hospital.
The Side-effects These can be discussed under two headings: (1) Those due to pituitary upset;
(2) Those due to the upset of the electrolyte balance.
The pituitary upset gives rise to Cushing-like changes which are manifested by a rounding of the facial contours, hirsuties with a growth of hair on the face, purple 14 strie, comedones, amenorrhcea and depression. These occur usually after about two -weeks but in one case began earlier in treatment. In another case we saw that wellmarked purple striae had been produced across the buttocks.
The upset in the electrolyte balance may give rise to cedema due to the sodium chloride retention and to alkalosis.
A.C.T.H. has given rise to severe headache and vomiting on occasion. Cortisone and A.C.T.H. have to be continued indefinitely; unfortunately directly the drug is stopped the symptoms return within a few days and the sedimentation rate rises again. It must be remembered that only severe cases have been treated so far but it does look as if treatment has to be continued.
The difficulties of production are immense and 39 long and difficult steps have to be passed before a minute yield of Cortisone is gained from desoxycholic acid. Apparently with the finding of Strophanthus sarmentosus this number has been reduced to 17 but the chemists still face a most difficult procedure. Owing to these difficulties, only 17 cases had been treated by June 1949 at the Mayo Clinic though some of these had been under treatment and control periods for over six months. It may be said that this is too few to establish the remarkable claims made, but all except one had responded dramatically.
One of the most remarkable moments at the international Congress on Rheumatism was when, after Dr. Hench and Dr. Kendall had delivered their papers on Cortisone, five physicians who were known to be extremely critical of any claims for the successful treatment of rheumatoid arthritis, who had been invited by the Mayo Clinic and each given sufficient to treat one case under his own control, came on to the platform and confirmed the remarkable effects of this drug in their own cases.
Apart from applauding the authors and their brilliant piece of research we should consider what advance has been made in the study of rheumatic diseases.
To my mind there are two main points of progress even before the drugs are available to study on our own cases. Point 1 is that it has been shown for the first time that the progress of rheumatoid arthritis is rapidly reversible by a drug. Dr. Hench has pointed out that the condition is reversible in pregnancy and sometimes in jaundice and now a drug has been found that can do the same thing. Point 2 is, I believe, equally important: we have a yardstick to evaluate treatment. The trouble with the treatment of rheumatoid arthritis has been that there are so many forms that improve the patient up to a point. Some are better than others and I believe myself that gold is one of the good ones but it is almost impossible to demonstrate that any one of ten or more treatments is better than another.
The rapid and dramatic improvement with Cortisone and A.C.T.H. is most striking compared with anything we have seen before, or any other present-day Dr. Raymond Greene: Some Endocrinological Aspects of Rheumatoid Arthritis. The realization of the r6le of the adrenal cortex in the xetiology of rheumatoid arthritis seems to have come with shock-like suddenness to the profession at large. In fact, however, many workers on both sides of the Atlantic have been studying the question for some years (e.g. Coke, 1945, and Bassi, 1946) . Much of this work is doubtless unfinished and therefore still unpublished, but as early as 1944 Selye and others claimed to have produced arthritis in nephrectomized rats with D.C.A. combined with a high salt intake. His results were disputed by Harrison in 1946, but whatever may be the ultimate judgment on Selye's results his paper focused further attention upon the adrenal cortex, an attention which became still more intense with the publication of his monograph on the General Adaptation Syndrome in 1946.
My own interest in the subject began some twelve years ago. Whereas Hench and his colleagues reached their inspired guess by a study of two conditions (jaundice and pregnancy) which alike may cause a temporary remission of the disease, I approached the problem by a different path, preferring rather to seek the common factor in a number of apparently distinct conditions often associated with the onset of the disease-puberty, lactation, the cimacteric, psychological strain, infection and perhaps thyrotoxicosis. The hypothalamic-endocrine system appeared to be a possible connecting link between these apparently various exciting causes, and, within this system, the adrenal cortex the most likely area to explore.
In April 1944 a patient was admitted under my care to Tindal House Emergency Hospital, Aylesbury, suffering from extremely severe rheumatoid arthritis, his condition strongly resembling that of the next patient to be described. I treated him with Eucortone, D.C.A., and anterior pituitary corticotrophic hormone without producing any improvement. Despite later recourse to all orthodox methods he died some months later. In the light of the Mayo Clinic report it seems likely that the sample of corticotrophin was inactive. The difficulty of obtaining corticotrophin caused me for some time to concentrate my attention on the possible effects of whole adrenal extracts and of D.C.A., both of which I found to be ineffective. These are, I gather, under trial in the U.S.A. I can assure workers there that their efforts are vain.
On November 25, 1946, a labourer aged-28 was admitted to the Metropolitan, Hospital in an apparently moribund condition. In addition to rheumatoid arthritis of a greater severity than I had previously seen, he had severe pemphigus.
[Here Dr. Raymond Greene described in detail the history, investigations and the general measures of treatment given.] In addition to these general measures, adopted of necessity and in the full realization that they seriously vitiated the scientific value of the experiment, I set up an intravenous procaine drip, a course which demands some explanation.
I had abandoned the use of whole cortical extracts and of D.C.A. as useless and the difficulty of obtaining corticotrophin in quantity had caused me to seek other methods of stimulating the adrenal cortex. It appeared possible (Ungar, 1944) that procaine, perhaps acting by way of the anterior pituitary, might be such a substance. This point will be the subject of a separate communication.
Within two days of beginning treatment with procaine improvement was noticeable. His joints became less painful and could be moved gently through a few degrees without pain. His morale, which had sunk to a very low ebb, improved. The pemphigus ceased to spread and the E.S.R. dropped from 90 mm. to 40, and at the end of a fortnight of treatment to 16 mm. Apart from this last rather unreliable criterion it might be suggested that improvement was due to the anasthetic properties of procaine, a possibility which cannot be dismissed. Against such a supposition is the fact that improvement continued (though more slowly) after the cessation of treatment. By the end of December 1946 he could eat solid food and the pemphigus was clearing rapidly. In January the E.S.R. was 10 mm. and his joints were free from pain. He got up on February 8, 1947, when he was weighed for the first time. He weighed 7 st. 2 lb. (45 4 kilos) and it was thought that he had put on about two stones (12.7 k.). Improvement continued, but very slowly, and in early March slight deterioration began, though the E.S.R. was still normal. By this time I had obtained some corticotrophin through the kindness of Dr. A. Macbeth of Organon. A course of daily intramuscular injections was begun on March 6 and continued until March 23. The daily dose was only 2-3 mg. A great improvement occufred during treatment but was not afterwards maintained. In May his E.S.R. was found to be 45 mm. On May 6 procaine injections were started again and continued until June 9. The E.S.R. dropped to 9 mm.
From that time functional improvement continued very slowly, but the disease remained inactive and he was finally discharged on December 15, 1947, with no disability other than a painless deformity of his hands. He has remained well ever since ; he is, as far as I have been able to determine, the first patient to be treated successfully for rheumatoid arthritis with corticotrophin. [Dr. Raymond Greene then demonstrated the case.] His continued good health requires explanation. Hench's patients need continued treatment. The most likely explanation seems to be that at some time during 1947 a spontaneous remission was "due." Those who saw him on his admission are convinced that he would not, without the treatment he received, have lived to enjoy that remission. Nevertheless I remain loth to attach much significance to a "cure" produced by so many concurrent methods of treatment.
One other patient was treated successfully with corticotrophin in March 1947. The difficulty of obtaining supplies then caused me to concentrate my attention on other possible methods of producing increased adrenal cortical activity and in particular on the effects of adrenaline (Vogt, 1944) , iso-propyl-noradrenaline, the antihistamine drugs, ascorbic acid, nupercaine, and procaine, substances which have an inhibitory effect on histamine release (Ungar, 1944) . It is interesting to note at this point that procaine hydrochloride is the hydrochloride of the base prepared by the interaction of chloroethyldiethylamine and sodium para-aminobenzoate. Benadryl is chemically a closely allied substance. I am not ready yet to make any statement on the majority of these substances, but it may be of interest to report briefly on 12 patients, all of whom have received procaine by slow intravenous infusion.
Of 3 who received under 10 grammes, 1 showed a moderate improvement and 2 no improvement. Of 4 who received between 10 and 20 grammes, 2 were improved to the extent of a temporary cure, 1 was moderately improved, and 1 not improved. Of 5 who received over 20 grammes, improvement amounting to temporary cure occurred in 2, moderate improvement in 2 and slight improvement in 1.
This improvement may have been the result of the local anesthetic action of procaine or of some other mechanism entirely unrelated to the adrenal cortex. Moreover we cannot regard the use of intravenous procaine as a serious advance in treatment. It shares with Cortisone and corticotrophin, which are far more effective, the disadvantages of affording usually only temporary relief and is, in addition. impracticable except in hospital. If, however, its effects are indeed mediated through the adrenal cortex, as Ungar's experimental work suggests, the clinical improvement produced is of theoretical interest in that it draws attention to the possibility of attaining our ends by means less difficult in practice than the use of Cortisone or corticotrophin. My reason for suggesting that the effects of procaine are not dependent on its local anxsthetic effect now needs explanation.
It has long been a matter of interest to those concerned with both rheumatology and endocrinology that in two types of rheumatoid arthritis, Still's disease and Felty's syndrome, the joint changes are associated with enlargement of the spleen. Since 1932, a number of reports have occurred of improvement in rheumatoid arthritis after splenectomy, including one by Bach and Savage in 1940, and by Bach in 1946 . In this latter report Bach drew attention to the rise in blood cholesterol in starvation, pregnancy and jaundice and after splenectomy, and pointed out that cholesterol may well be the mother substance of the sterols of the adrenal cortex. The results of splenectomy are so unreliable (Coburn and Pauli, 1935) that the operation has been abandoned. Nevertheless the hint may be worth taking.
In 1945, Ungar claimed to have demonstrated the presence of two substances in the serum of traumatized guinea-pigs. One, which he afterwards called splenin A, decreases bleeding time and the other, which he called splenin B, increases it. Splenin A increases capillary resistance and inhibits histamine release. He claimed that the release of splenin A is dependent upon a chain of events beginning with trauma, which produces an increase in the output of corticotrophin from the anterior pituitary, which causes an increase in the activity of the adrenal cortex, which in turn causes the output of splenin A from the spleen. He suggested that an increase in splenin A might be part of the alarm reaction of Selye, and stated that splenin A is present in normal human blood, whereas splenin B is not. His experiments have not yet been confirmed.
Selye having already hinted at the possibility of rheumatoid arthritis being an example of a failure of his alarm reaction (a suggestion made probable by the great variety of traumata which may apparently initiate the disease), it occurred to me that it would be worth while to determine whether these substances were present in the blood of patients suffering from rheumatoid arthritis. I therefore supplied Dr. Ungar with six specimens of blood from patients suffering from various disorders unknown to him. He reported a complete absence of splenin A and the presence of splenin B in the 2 patients mentioned above who were afterwards treated with corticotrophin. After corticotrophic therapy, splenin B disappeared from the blood and splenin A was found. The other four bloods contained normal amounts of splenin A and no splenin B.
Ungar has since reported the presence of splenin B in the blood of patients with scurvy, various himorrhagic conditions, acute rheumatism and thyroid deficiency. Miss Vaughan-Morgan, who was taught the technique by Dr. Ungar, working under my direction at the Royal Northern Hospital, has found it in some cases of thyrotoxicosis.
Ungar and I then proceeded to look for splenin A and B in the blood of a number of patients suffering from active rheumatoid arthritis, some of them under my care Thyrotoxicosis, before operation 9 4 5 6 3
In 3 cases tested also after operation, A was absent before and after, and B was increased.
Combining the series it is seen that of 25 cases of clinically active rheumatoid arthritis, splenin B was present in the blood of all but 2. Splenin A was present also in that of 5 only. The blood of 3 cases of inactive rheumatoid arthritis contained splenin A but no splenin B.
No conclusions can be drawn from the results in other disorders, but Ungar, Vaughan-Morgan and Bergel all found A present in and B absent from the blood of all healthy controls.
In the blood of the 2 patients with rheumatoid arthritis treated with corticotrophin, splenin A was absent and splenin B present before treatment; but splenin A present and B absent afterwards. The results were less clear-cut in the patients treated with procaine.
Dividing the cases as before, according to total dosage received, the following results were recorded: 
Moderate improvement
From this it will be seen that the 3 cases of rheumatoid arthritis which failed to improve all showed splenin B in the blood before and after treatment. In these 3 splenin A either disappeared or was never present. I  II  III   IV  V  VI  VII VIII Ix x XI XII Result J Of those 9 cases which improved, all those tested showed the disappearance of splenin B during treatment and in 3 cases the reappearance of splenin A, previously absent.
Case

No. Dose
DiscUSSION
I fully realize that these findings are incomplete. My excuse for their premature publication is my belief that the time has come for all those who have in their possession any information which may possibly be relevant to the issue to place it at the disposal of workers on the subject of the endocrine aspects of rheumatoid arthritis. Only one definite fact emerges-that the blood of patients with rheumatoid arthritis usually contains a substance which increases the bleeding time of guineapigs and that this substance is usually absent after the treatment of the patients with corticotrophin or with large intravenous doses of procaine.
If Ungar's work on the spleen can be confirmed, my results afford a prima facie case for further work on the part which may be played by the spleen in the oetiology of rheumatoid arthritis.
BIBLIOGRAPHY BACH, F. (1946 ) Proc. R. Soc. Med., 39, 306. -and SAVAGE, 0. (1940 Ann. Rheum. Dis., 2, 47. BASSI, M., and BASSI, G. (1946) Endocr. Sci. Costit., 18, 189. BERGEL, F. (1947) Personal communication. COBURN, A. F., and PAULI, R. H. (1935) Dr. Max Reiss: As far as I am aware, Hemphill and Reiss were in 1942 the first to treat patients with biologically standardized and purified adrenocorticotrophic hormone. The patients were a group suffering from involutional melancholia. Apart from the mental improvement a skin phenomenon was described which might be of interest for this meeting. " In every case the skin soon began to look and feel to the touch moremsupple and thicker ... the hair of the head regained its lustre, losing some of its dry brittle quality." Later we saw that the skin became more elastic and its electrical conductivity decreased. Excretion of 1 7-ketosteroids was shown to be increased. We used only a dose equivalent to 1-5 -3 mg. of one of the present American preparations. Their dose is many times higher than the hormone produced physiologically. The pharmacological action of such doses, apart from the beneficial effects as in rheumatism, can produce diabetic changes, alterations in the blood pressure and so on. These high doses will ultimately be used, as Thorn and his co-workers suggest, to test the reaction capacity of a patient's adrenal cortex only. Physicians dealing with rheumatism will have an opportunity to study biochemical changes involved in the rheumatic symptom complex. But therapeutic measures will be designed to increase endogenous production of corticotronhic hormone. Dr. M. G. Good: I am very sorry to pour cold water on the hopes raised by the speaker; in the official report of the New York Congress, Hench et al. claimed no cure, not even a treatment but an investigation into a treatment of rheumatoid arthritis. The evidence available to date on a relatively small number of cases treated for a short time shows that daily injection of 100 mg. of Cortisone relieves the pain completely and thus enables movement in the diseased joints. However, this is due to a temporary relief of pain, and after cessation of the injection the patient is as bad as before, including a raised E.S.R. Hench himself called Cortisone "dynamite", which obviously cannot be given for months and years. The hypothesis that a deficiency of Cortisone is the cause of rheumatoid arthritis is at variance with clinical observations. In Addison's disease no rheumatoid arthritis or rheumatism have been observed ! On the other hand it is necessary to point out the very close chemical relation between the structural formulas of Cortisone and other potent natural hormones, like sexual hormones and D-vitamin. Daily injections of enormous and unphysiological doses of Cortisone must needs produce unpleasant side-effects such as virilism in women, painful gynecomastia in men. Among others the danger of malignant new growths cannot be excluded at present.
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In contrast to the "dynamite" Cortisone I have been obtaining in the last twelve months excellent therapeutic results-I might even say a cure in rheumatoid arthritis (about 80-90 cases) by injection of procaine into specific "myalgic spots". [The cases were demonstrated at the meeting of the Clinical Section on October 14, 1949.] Dr. Francis Bach: Compound E or Cortisone is not, in my opinion, and never will be, the treatment for rheumatoid arthritis. It is interesting to consider how, in the last twenty years, we who are interested in the study of rheumatism have seen, and even taken part in, the early phase of "focal infection", then that of focal conflict (psychosomatic studies) and now have returned to Sydenham's holistic approach.
The fundamental and dramatic work of Kendall, Hench and Thorn which we saw in America has advanced our understanding of man's endocrine system, and, in particular, the mechanism of the hypothalamic, anterior pituitary adrenotrophic, thyrotrophic, gonadotrophic splenic relationship. I would mention two points of possible interest in this connexion. In those rheumatic patients to whom Dr. Greene referred who, some years ago, at my instigation, had their spleens removed, the disease has remained clinically "inactive". In one patient in whom the clinical picture was first that of an acute thyrotoxicosis, apparently with a normal basal metabolic rate, thyroidectomy was performed. This was followed immediately by the onset of an acute rheumatoid type of arthritis, with swelling of the joints and gross muscle spasm. There was no response to any of the orthodox methods of treatment. Then, some five years ago, splenectomy was performed and complete relief of muscle spasm and the disappearance of all clinical and laboratory signs of activity followed. Now the patient is undergoing a series of operations for joint reconstruction by Mr. Timbrell Fisher, the orthopedic surgeon. Dr. Raymond Greene: So far as I am aware'there is no known explanation.
